Halima Rahmtoola

Halima Rahmtoola currently serves as the Clinical Risk Strategist at Discovery Limited, where she leverages her extensive expertise to enhance the company’s risk management frameworks within the healthcare and medical scheme sectors. In this pivotal role, Halima is responsible for identifying, assessing, and mitigating clinical and operational risks that could impact the sustainability and compliance of Discovery’s diverse medical schemes. Her strategic approach involves analyzing complex data sets to uncover potential vulnerabilities, developing innovative risk mitigation strategies, and implementing proactive solutions that align with both regulatory requirements and the company’s long-term business objectives.

A key aspect of Halima’s role involves collaborating closely with cross-functional teams, including actuarial, clinical, and operational departments, to ensure comprehensive risk oversight. She plays a vital role in preparing detailed reports and presentations for the Schemes’ Boards of Trustees, providing insights that inform strategic decision-making and governance. Her expertise in business analysis, combined with her strong communication skills, enables her to translate complex clinical risk data into actionable insights, fostering a culture of continuous improvement and risk awareness across the organization.

With over two decades of experience managing risk across open, restricted access, and low-income medical schemes, Halima’s broad industry knowledge and analytical acumen position her as a trusted leader in clinical risk management. Her proficiency in strategic development, program management, and operations management ensures that Discovery’s risk mitigation initiatives are both innovative and effective, ultimately supporting the company’s mission to deliver sustainable, high-quality healthcare solutions.